Alpha 1 antitrypsin deficiency in children with chronic liver disease in North India

Narendra K Arora1, Shivali Arora, Anjali Ahuja

  • 1International Clinical Epidemiology Network (INCLEN), Division of Pediatric Gastroenterology, Hepatology and Nutrition, All India Institute of Medical Sciences, New Delhi 110 020, India. nkarora@inclentrust.org

Indian Pediatrics
|May 11, 2010
PubMed

Insights

Alpha-1-antitrypsin (AAT) deficiency variants are uncommon causes of chronic liver disease in North Indian children. A novel AAT mutation was identified in two siblings with liver disease.

Area of Science:

  • Genetics
  • Hepatology
  • Pediatrics

Background:

  • Alpha-1-antitrypsin (AAT) deficiency is a genetic disorder that can lead to liver disease.
  • The prevalence of AAT deficiency as a cause of chronic liver disease in North Indian children is not well-established.

Purpose of the Study:

  • To determine the role of alpha-1-antitrypsin (AAT) deficient variants in causing chronic liver disease among North Indian children.
  • To investigate the genetic basis of AAT deficiency in pediatric liver disease patients.

Main Methods:

  • A study of 1700 children, including 840 with chronic liver disease (CLD), 410 with neonatal cholestasis, and 450 controls, was conducted.
  • Screening tests for AAT deficiency included low serum AAT levels, absent/faint alpha-1-globulin band, and PAS-positive granules on liver biopsy.
  • Genetic analysis (PCR-RFLP, SSCP, sequencing) was performed on suspected cases to identify AAT deficient Z or S alleles and novel mutations.

Main Results:

  • No Z or S alleles of AAT deficiency were found in any of the 1700 subjects.
  • A novel mutation (G-to-A at position 333 in exon V) was identified in two siblings with significant liver disease and portal hypertension.
  • These siblings showed positive immunohistochemistry for AAT on liver biopsy.

Conclusions:

  • Alpha-1-antitrypsin deficiency is an uncommon etiological factor for chronic liver disease in childhood in North India.
  • A novel AAT mutation may contribute to liver disease in specific pediatric cases.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...